瑞财经 刘治颖12月16日,成都迈科康生物科技股份有限公司(以下简称:迈科康生物)在四川证监局完成IPO辅导备案,拟A股上市,辅导机构为中金公司。迈科康生物成立于2016年,注册资本3726.13万元,是一家致力于创新疫苗和新型佐剂研发、生产和商业化于一体的全球生物医药企业,获得国家级高新技术企业、四川省专精特新“小巨人”企业认定。迈科康生物针对传染性、过敏性疾病及肿瘤领域布局了多样化的产品研发...
Source Link瑞财经 刘治颖12月16日,成都迈科康生物科技股份有限公司(以下简称:迈科康生物)在四川证监局完成IPO辅导备案,拟A股上市,辅导机构为中金公司。迈科康生物成立于2016年,注册资本3726.13万元,是一家致力于创新疫苗和新型佐剂研发、生产和商业化于一体的全球生物医药企业,获得国家级高新技术企业、四川省专精特新“小巨人”企业认定。迈科康生物针对传染性、过敏性疾病及肿瘤领域布局了多样化的产品研发...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.